The role of interleukin-6 in diabetic retinal disease: pathophysiology and therapeutic targeting
Therapeutic strategies in the management of diabetic retinal diseases have typically employed anti–vascular endothelial growth factor A (anti–VEGF-A) therapies. While generally effective, clinical trials and real-world analyses demonstrate that a subst…